News & Analysis on Clinical Trial Services & Contract Research And Development
The recent FDA guidance ties penalties for not disclosing clinical trial results to formal inspections – falling short of the public expectation that such data should be readily available, says industry expert.
Icon has launched an integrated technology platform for the design, simulation, and analysis of adaptive clinical trials.
The companies announced a partnership to integrate 4G’s technology with Clarkston’s clinical supply chain services in an aim to enrich clinical trial strategy and operations.
The US FDA has issued a warning letter to a compounding pharmacy in California, US, after a facility inspection revealed FDCA violations.
Following a review of its Ulverston site, GSK announced at the end of last week it would shed positions related to the manufacture of active ingredients for sterile injections.
Dr. Reddy’s Laboratories antibiotic manufacturing site in Bristol, Tennessee, has been sold to Neopharma, along with all issued and outstanding membership interests and related assets.
The new season has brought a change in line-up for some companies with new hires and retirements, but for some it meant changing the rules to keep key players.